Research and Development

Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …

Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …

Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. “Our office, strategically located in suburban Pilar, is a natural …

UK drug delivery specialist PolyTherics has raised an additional £3 million in funding as it extends the focus of its …

AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …

PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …

Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …

MDS has completed the sell-off of its contract research and development business – MDS Pharma Services – with the signing …

Our round-up of developments in the contract research sector includes alliances for Parexel/Proteome Sciences and SIRO Clinpharm/DreamCIS, as well as …

Jan van Heek has joined Amarin’s board of directors of as a non-executive director and will also take on the role …

Management Forum is pleased to announce the launch of their PHARMACY 2010 Exhibition website.  This exciting new website contains full …

Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …

A novel formulation of ondansetron has seen its marketing application delayed at the US Food and Drug Administration (FDA) because …

GlaxoSmithKline is on the point of making the first job cuts in a round of redundancies designed to save £500 …

How did you find your way into your most current role? After receiving a master’s degree in biology at the …